This anitbody is made to an epitope that is reported to block the PCSK9-LDLR (low density lipoprotein receptor) interaction. PCSK9 binds to the EGF-A domain of the LDLR and signals LDLR degradation. Reduced LDLR levels result in decreased LDL (low densit
Provided as solution in phosphate buffered saline with 0.08% sodium azide
Purity:
Antigen Immunoaffiinity Purification
Formula:
Provided as solution in phosphate buffered saline with 0.08% sodium azide
Application Notes:
Antibody can be used for Western blotting (1:400 dilution) and immunocytochemisty (2 µg/ml). Optimal concentration should be evaluated by serial dilutions.
* VAT and and shipping costs not included. Errors and price changes excepted